CytoDyn color logo - no R.png
CytoDyn to Release CD12 Trial Detailed Results via Form 8-K After Investment Community Webcast, Monday, March 8
March 08, 2021 06:10 ET | CytoDyn Inc.
These trial results are currently being prepared to be submitted for publication VANCOUVER, Washington, March 08, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"),...
ReportLinker logo.jpg
The global high-throughput screening market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5%
March 08, 2021 06:09 ET | ReportLinker
New York, March 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "High-Throughput Screening Market by Product, Technology, Application, End User - Global Forecast to...
22157.jpg
Worldwide Braking Resistor Industry to 2027 - Booming Mining Sector Presents Opportunities
March 08, 2021 06:08 ET | Research and Markets
Dublin, March 08, 2021 (GLOBE NEWSWIRE) -- The "Braking Resistor Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Resistor Element Type and End-User" report has been added to...
CytoDyn color logo - no R.png
CytoDyn to File Accelerated Rolling Review with MHRA and Interim Order (IO) with Health Canada for COVID-19
March 08, 2021 06:05 ET | CytoDyn Inc.
U.S. FDA Reviewing Protocol for More COVID-19 Critical Patients to be Enrolled to Support Potential EUA CytoDyn submitted protocol to U.S. FDA for immediate enrollment of 140 critical COVID-19...
Logo.PNG
Zomedica Retires Preferred Shares
March 08, 2021 06:05 ET | Zomedica Corp.
ANN ARBOR, Mich., March 08, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...
ReportLinker logo.jpg
Big Data Security Market by Component, by Software, Deployment Type, Organization Size, Vertical And Region - Global Forecast to 2026
March 08, 2021 06:04 ET | ReportLinker
New York, March 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Big Data Security Market by Component, by Software, Deployment Type, Organization Size, Vertical...
22157.jpg
Global Telehealth Market (2020 to 2025) - by Component, Application, Mode of Delivery, End-user and Geography
March 08, 2021 06:03 ET | Research and Markets
Dublin, March 08, 2021 (GLOBE NEWSWIRE) -- The "Global Telehealth Market (2020-2025) by Component, Application, Mode of Delivery, End-User, Geography, Competitive Analysis and the Impact of Covid-19...
Graphical Research.jpg
Emergency Medical Supplies Market Statistics | North America, Europe, & APAC Industry Forecasts 2026: Graphical Research
March 08, 2021 06:00 ET | Graphical Research
Pune, India, March 08, 2021 (GLOBE NEWSWIRE) -- The global emergency medical supplies market is predicted to observe lucrative growth rate during the forecast period, with numerous healthcare...
CytoDyn color logo - no R.png
CytoDyn’s Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and Faster Hospital Discharge for Mechanically Ventilated Critically Ill COVID-19 Patients Treated with Leronlimab
March 08, 2021 06:00 ET | CytoDyn Inc.
VANCOUVER, Washington, March 08, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a...
RadNet-Logo-Tag-Stacked-Medium-Color.jpg
RadNet Reports Fourth Quarter Results with Record Revenue and Adjusted EBITDA and Releases 2021 Financial Guidance
March 08, 2021 06:00 ET | RadNet, Inc.
Despite the ongoing impact of COVID-19, RadNet reports record fourth quarter 2020 Total Net Revenue (“Revenue”) of $308.5 million and Adjusted EBITDA(1)of $50.7 million; Revenue increased 2.5% and...